Discover

AVNS
Avanos Medical, Inc.
24.99
46800 x 24.92
3700 x 24.90
bid
ask
+
0.00
0.00%
25250 @ 04:03 PM
24.95 -0.04 (0.16%)
Ytd122.53%
1y105.34%
24.98
day range
25.00
10.63
52 week range
25.49
Open24.98Prev Close24.99Low24.98High25.00Mkt Cap1.17B
Vol432.16KAvg Vol700.36KEPS-1.61P/E-16.65Forward P/E19.99
Beta1.57Short Ratio2.05Inst. Own93.15%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0550-d Avg24.90200-d Avg17.161yr Est14.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-08-102026-060.16N/AN/AN/A
2026-05-052026-030.160.220.0637.50%
2026-02-242025-120.240.290.0520.83%
2025-11-052025-090.120.220.183.33%
2025-08-052025-060.180.17-0.01-5.56%
2025-05-062025-030.190.260.0736.84%
Upgrade / Downgrade
DateFirmActionFromTo
2024-05-07JMP SecuritiesUpgradeMarket Perform
2023-07-25KeybancDowngradeOverweightSector Weight
2023-06-21StifelUpgradeHoldHold
2023-05-22CL KingUpgradeBuy
2023-05-04Morgan StanleyUpgradeUnderweight
2023-02-22Morgan StanleyUpgradeUnderweight
Profile
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Insider Holder
DateNameRelationQuantityDescription
2025-08-12BLACKFORD GARY DDirector0.00Purchase
2026-03-12DELGADO SIGFRIDOOfficer60.01KStock Award(Grant)
2026-03-12GALOVAN SCOTT MICHAELChief Financial Officer139.82KStock Award(Grant)
2025-03-06GREINER MICHAEL CChief Executive Officer224.26KStock Award(Grant)
2025-11-17HOLBROOK KERROfficer83.86KSale
2025-04-21JAMES MOJIRADEGeneral Counsel104.52KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Blackrock Inc.6.84M171.02M14.61%
2026-03-30T. Rowe Price Investment Management, Inc.5.33M133.22M11.38%
2026-03-30Brown Advisory Inc.2.23M55.76M4.76%
2026-03-30Dimensional Fund Advisors LP2.05M51.29M4.38%
2026-03-30Armistice Capital, LLC2.00M49.98M4.27%
2026-03-30Vanguard Capital Management LLC1.97M49.28M4.21%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30T. Rowe Price Small-Cap Value Fund, Inc.2.84M70.95M6.06%
2026-05-30iShares Trust-iShares Core S&P Small-Cap ETF2.81M70.30M6.00%
2026-03-30-Price (T.Rowe) U.S. Small-Cap Value Equity Trust1.85M46.18M3.94%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.41M35.25M3.01%
2026-06-29iShares Trust-iShares Russell 2000 ETF1.20M29.96M2.56%
2026-03-30Thrivent ETF Trust-Thrivent Small-Mid Cap Equity ETF951.47K23.78M2.03%